At the end of the 2015/16 fiscal year on June 30, 2016, TRUMPF (Ditzingen, Germany) recorded a 3.4% sales increase. The figure amounts to 2.81 billion euros, up from 2.72 billion euros the previous year. At 2.79 billion euros, incoming orders were below the previous year's 2.82 billion level.
Consolidated income before taxes amounted to 303 million euros, a 15.2% decrease from the previous year (357 million euros). However, in fiscal year 2014/15, the one-off effect from the sale of the company's medical technology division positively impacted the result by 72 million euros. Adjusted for this effect, earnings rose by 6.3% in 2015/16. The return on sales was 10.8%—in the previous year, the return was 13.1%, but was adjusted to 10.5% because of the sale of the medical technology division.
"We were unable to repeat the strong sales growth of the previous financial year," summarized Dr. Nicola Leibinger-Kammüller, chairwoman of the TRUMPF Managing Board. "But in view of the global economic factors, this result is very satisfactory for an export-oriented company." In this regard, she mentioned the weak economic situation in China and Brazil, the sanctions against Russia, and also the uncertainty caused by the Brexit referendum, which has also affected other countries—for example, in Eastern Europe.
Among the reasons for its sales increase, the company mentioned the development of some regional markets in Western Europe and overseas. The company achieved double-digit sales growth in Spain (50%). In France, too, sales again reached pre-recession levels (19.6%), while in Germany, sales rose by 5.2% to 597 million euros. In China, the economy was slightly less dynamic, so revenues there totaled around 368 million euros, a decrease of roughly 0.5% compared to the previous year. The US remained similarly stable (0.3% to 370 million euros).
Leibinger-Kammüller went on to say that over the past year, the company has driven targeted investments in the future, including the development of new machines, the founding of a venture capital company to support startups, as well as structural expansion of its locations in Germany and abroad. In total, the company invested 138 million euros (6.3% compared to last year), partially in structural expansion, and also acquired software companies such as Xetics in Stuttgart and C-Labs in the US to strengthen its digital strategy.
Moreover, TRUMPF is aiming at a significant personnel increase in the area of additive manufacturing. Leibinger-Kammüller mentioned that up to 100 new jobs would be created during the current fiscal year, most of them in Ditzingen, and a further increase of at least 100 more is planned for the coming fiscal year of 2017/18.
For the current fiscal year, the company is aiming for sales growth in the medium single-digit percentage range.
For more information, please visit www.trumpf.com/en.